Table 1.
Clinical and Histological Characteristics of the Human PCC/PGL Primary Cultures From Seven Different Patients
| Patient | Age | Sex | Tumor | Metastatic | Histology and Criteria of Malignancy | Ki-67 (%) | NGS of the Tumors |
|---|---|---|---|---|---|---|---|
| 1 | 82 | M | Adrenal pheochromocytoma | No | Tumor size: 1.5 cm; capsule invasion | 1–2 | No known susceptibility mutation |
| 2 | 50 | M | Adrenal pheochromocytoma | No | Tumor size: 12.9 cm; nuclear pleomorphism | 1–2 | NF1 mutation |
| 3 | 73 | F | Adrenal pheochromocytoma | No | Tumor size: 3.9 cm; nuclear and cell pleomorphism | 2 | NF1 mutation |
| 4 | 26 | M | Adrenal pheochromocytoma | No | Tumor size: 3.2 cm; vascular invasion, anisonucleosis, cell inclusions | 5 | No known susceptibility mutation |
| 5 | 65 | M | Adrenal pheochromocytoma | No | Tumor size: 5 cm | <1 | Not assessed |
| 6 | 60 | M | Adrenal pheochromocytoma | No | Tumor size: 5.5 cm; capsule invasion, vascular invasion | <1 | Not assessed |
| 7 | 30 | F | Uterus metastasis | Yes | Tumor size: 5.3 cm | 20 | Variant of unknown significance in TET1 |
| Lymph node metastasis | Yes | Tumor size: 2.5 cm | 20 |
Abbreviations: F, female; M, male.